AstraZeneca PLC
F:ZEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AstraZeneca PLC
F:ZEG
|
UK |
|
A
|
ASML Holding NV
DUS:ASME
|
NL |
|
E
|
Eldorado Gold Corp
SWB:ELO1
|
CA |
|
B
|
Bayerische Motoren Werke AG
MIL:BMW
|
DE |
|
Champion Real Estate Investment Trust
F:Q9S
|
HK |
|
P
|
Philip Morris International Inc
SWB:4I1
|
US |
|
First Community Bankshares Inc
NASDAQ:FCBC
|
US |
|
Abb Ltd
OTC:ABBNY
|
CH |
|
E
|
EcoSynthetix Inc
OTC:ECSNF
|
CA |
|
Vodacom Group Ltd
F:5VD0
|
ZA |
|
I
|
International Business Machines Corp
F:IBM
|
US |
|
A
|
Anglo American PLC
SWB:NGLB
|
UK |
Wall St Price Targets
ZEG Price Targets Summary
AstraZeneca PLC
According to Wall Street analysts, the average 1-year price target for ZEG is 190.76 EUR with a low forecast of 132.23 EUR and a high forecast of 249.39 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZEG's stock price target?
Price Target
190.76
EUR
According to Wall Street analysts, the average 1-year price target for ZEG is 190.76 EUR with a low forecast of 132.23 EUR and a high forecast of 249.39 EUR.
What is the Revenue forecast for AstraZeneca PLC?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 6%.
What is the Operating Income forecast for AstraZeneca PLC?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 13%.
What is the Net Income forecast for AstraZeneca PLC?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 13%.
